J3370 HCPCS Level II code: Injection, vancomycin hcl, 500 mg
CMS terminated J3370: its last date of service was Jun 30, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
J3370Injection, vancomycin hcl, 500 mg
Short description: Vancomycin hcl injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J3370 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1986
- Terminated after
- Jun 30, 2025
Where J3370 sits
- 1J codesDrugs administered other than orally
- 2Terminated J3370Injection, vancomycin hcl, 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J3370 still valid?
No. CMS terminated J3370; its last date of service was Jun 30, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J3370?
CMS lists J3370’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3370
All J codesJ3355Injection, urofollitropin, 75 iuJ3357Ustekinumab, for subcutaneous injection, 1 mgJ3358Ustekinumab, for intravenous injection, 1 mgJ3360Injection, diazepam, up to 5 mgJ3364Injection, urokinase, 5000 iu vialJ3365Injection, iv, urokinase, 250,000 i.u. vialJ3371Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mgJ3372Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mgJ3373Injection, vancomycin hydrochloride, 10 mgJ3374Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mgJ3375Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mgJ3376Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg